Former AstraZeneca, Portugal
Medical Manager Oncology
I have a University Degree in Life Sciences (Chemistry – Biotechonology) and a post graduation on Clinical Trials. I have worked 3 years as a scientist and 13 years in medical affairs, in the pharmaceutical industry, supporting the launch of several biologics and small molecules, in Oncology, Hematology, Rare Diseases and Inflammatory Diseases. In 2013, I accepted the challenge to be Medical Manager at Hospira Portugal, responsible for the launch of the first monoclonal antibody biosimilar. This anti-TNF alpha therapeutic is indicated for the treatment of several chronic, severe and highly disabling auto-immune diseases, including Rheumatoid Arthritis and Crohn’s disease. Portugal was one the first countries to launch this drug worldwide.
Bringing life changing therapeutics to patients, advancing health care professionals’ knowledge of diseases and improving patients outcomes is what makes me passionate about my work.